MexHealth LLC d/b/a Al Natural E-Shop – FDA Warning Letter, Sep 3, 2024
The FDA issued a Warning Letter to Mr. Travis Bunch regarding the product "Ossos-Sans" sold on alnaturaleshop.com. FDA website reviews in April and July 2024, and subsequent laboratory analysis of "Ossos-Sans" samples, revealed the product contains undeclared diclofenac and methocarbamol.
Diclofenac, an NSAID, carries risks of cardiovascular events and serious gastrointestinal damage. Methocarbamol, a muscle relaxant, can cause sedation, dizziness, and impaired abilities. The product is marketed as a dietary supplement but is excluded from this definition because diclofenac was approved as a new drug (Voltaren) before being marketed as a supplement or food.
"Ossos-Sans" is deemed an unapproved new drug under sections 505(a) and 301(d) of the FD&C Act, as its labeling claims (e.g., "Artritis," "Osteoporosis," "Dolores Musculares") indicate intended use as a drug, and it is not generally recognized as safe and effective. No FDA-approved applications exist for this product.
Furthermore, "Ossos-Sans" is a misbranded drug under sections 502(a) and 301(a) of the FD&C Act because its labeling fails to declare the presence of diclofenac and methocarbamol, rendering it false
ID · d6bfa0c8-3ba0-45ff-a5a8-69aa3f5755c0
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.